Vahaticor logo with a stylized globe icon and the company name in turquoise text.

Breakthrough Therapy for CMD


VahatiCor is a medical technology company focused on improving care for patients with CMD, a common but often overlooked cause of persistent angina. The company’s coronary sinus reducer is designed to enhance myocardial perfusion through a precise, controlled narrowing of the coronary sinus. This mechanism redistributes oxygenated blood to areas of the heart that need it most, with the aim of reducing angina symptoms and improving patients’ quality of life.

Web: vahaticor.com

Locations: Santa Clara, CA

Sectors: Healthcare Technology

S3 Investments: Series B

Leadership & Founders


Marwan Berrada, Co-Founder & CEO

Investment Team


Co-Investors


Intuitive Ventures

Company News